Serial Changes of Serum β-2-Microglobulin in Capd

Abstract

Get full access to this article

View all access options for this article.

References

Acchiardo

, Kraus

A.P.

, Jennings

B.R.

Beta-2 microglobulin levels in patients with renal insufficiency.

Am J Kidney Dis 1989; 13: 70–4.

Blumberg

, Burgi

Behavior of 13-microglobulin in patients with chronic renal faiure undergoing hemodialysis, hemofiltration and continuous ambulatory peritoneal dialysis (CAPD).

Clin Nephrol 1987; 27: 245–9.

Ballardie

F.W.

, Kerr

D.N.S.

, Tennent

, Pepys

M.B.

Haemodialysis versus CAPD: Equal predisposition to amyloidosis.

Lancet 1986; 1: 795–6.

Floege

, Bartsch

, Schulze

, Shaldon

, Koch

K.M.

, Smeby

L.C.

Clearance and synthesis rates of 132microglobulin in patients undergoing hemodialysis and in normal subjects.

J Lab Clin Med 1991; 118: 15365.

Tielemans

, Dratwa

, Bergmann

Continuous ambulatory peritoneal dialysis, protective against developing dialysis-associated amyloid.

Nephron 1989; 53: 174–5.

Schardun

G.H.C.

, Eps

L.W.S.

13-microglobulin: Its significance in the evaluation of renal function.

Kidney Int 1987; 32: 635–41.

Benbamou

C.L.

, Bardin

, Noel

L.H.

Beta-2microglobulin amyloidosis as a complication of peritoneal dialysis (Letter).

Clin Nephrol 1988; 29: 346.

Guh

J.Y.

, Lai

Y.H.

, Tsai

J.C.

, Tsai

J.H.

Effects of hemodialysis using ethylenevinyl alcohol (EVAL) dialyzer on blood beta-2-microglobulin levels in regular hemodialysis patients.

J Nephrol ROC 1990; 4: 13945.

Lysaght

M.J.

, Pollock

C.A.

, Moran

J.E.

, Ibels

L.S.

, Farrell

P.C.

Beta-2-microglobulin removal during continuous ambulatory peritoneal dialysis.

Perit Dial Int 1989; 9: 29–35.